Estrogen and progesterone receptor status in breast cancer: Effect of oral contraceptive pills and hormone replacement therapy

Breast

Volumn 16, Issue 5, 2007, Pages 540-545

  Tewari, Mallika ^a   Pradhan, S ^b   Singh, Usha ^a   Shukla, Hari S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Breast cancer; Estrogen receptor; Grade; Indian women; Oral contraceptive pills hormone replacement therapy; Progesterone receptor

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DESOGESTREL; ESTROGEN RECEPTOR; NORETHISTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CONFIDENCE INTERVAL; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 34848820017     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.05.005     Document Type: Article

References (21)

1. Donald E.H., Kenneth C.C., and Paul H.L. Histologic grade, stage and survival in breast carcinoma. Comparison of African American and Caucasian women. Cancer 98 (2003) 908-917
2. Desai S.B., Moonim M.T., Gill A.K., et al. Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 9 (2000) 267-270
3. Redkar A.A., Sampat M.B., Chinoy R.F., et al. Differences in estrogen receptor status and histological grade of breast cancer in different religious communities in Bombay. Indian J Cancer 28 (1991) 124-130
4. Moormeier J. Breast cancer in black women. Ann Intern Med 124 (1996) 897-905
5. Chen V.W., Correa P., Kurman R.J., et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3 (1994) 127-135
6. American Joint Committee on Cancer. AJCC cancer staging manual (1997), Lippincott-Raven, Philadelphia 172pp
7. Elledge R.M., and Fuqua S.A.W. Estrogen and progesterone receptors. In: Harris J.R., Lippman M.E., Morrow M., and Osborne (Eds). Diseases of the breast. 2nd ed (2000), Lippincott Williams & Wilkins, Philadelphia 471
8. Elledge R.M., Clark G.M., Channers G.C., et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86 (1994) 705-712
9. Chu K.C., Anderson W.F., Fritz A., et al. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92 (2001) 37-45
10. Standford J.I., and Greenberg R.S. Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health 79 (1989) 71-73
11. Fisher E.R., Anderson S., Tan-Chiu E., et al. Fifteen year prognostic discriminants for invasive breast carcinoma: NSABP protocol B-06. Cancer 91 (2001) 1679-1687
12. Cross C.K., Harris J., and Rect A. Race, socioeconomic status, and breast carcinoma in the US What have we learned from clinical studies?. Cancer 95 (2002) 1988-1999
13. Ahmed R., Shaikh H., and Hasan S.H. Is carcinoma breast a different disease in Pakistani population?. J Pak Med Assoc 47 (1997) 114-116
14. Chow L.W., and Ho P. Hormonal receptor determination of 1052 Chinese breast cancers. J Surg Oncol 75 (2000) 172-175
15. Nomura Y., Tashiro H., Hamad Y., et al. Relationship between estrogen receptors and risk factors of breast cancer in Japanese pre- and postmenopausal patients. Breast Cancer Res Treat 4 (1984) 37-43
16. Yeole B.B., and Kukure A.P. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pac J Cancer Prev 4 (2003) 51-56
17. Agarwal N., Deka D., and Takkar D. Contraceptive status and sexual behavior in women over 35 years of age in India. Adv Contracept 15 (1999) 235-244
18. Lower E.E., Blau R., Gazder P., et al. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast cancer Res Treat 58 (1999) 205-211
19. Li C.I., Daling J.R., and Malone K.E. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21 (2003) 28-34
20. Manjer J., Malina J., Berglund G., et al. Increased incidence of small and well differentiated breast tumors in post-menopausal women following hormone-replacement therapy. Int J Cancer 92 (2001) 919-922
21. Holli K., Isola J., and Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol 16 (1998) 3115-3120